- Acumen Powered by Robins Kaplan LLP®
- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Entertainment and Media Litigation
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Fiduciary Disputes
Acumen Powered by Robins Kaplan LLP®
Ediscovery, Applied Science and Economics, and Litigation Support Solutions
-
March 26, 2024Ronald Schutz, Brendan Johnson Named to Forbes Top 200 Lawyers in the United States
-
March 21, 2024Robins Kaplan Firm Members Appointed to Law360 Editorial Boards
-
March 20, 2024Brandon Vaughn Inducted into The International Society of Barristers
-
April 5, 2024Mass Torts Made Perfect
-
April 17, 2024American Antitrust Institute Virtual CLE Lunch & Learn
-
May 2-3, 2024ACI Advanced Forum on Managed Care Disputes and Litigation
-
March 14, 2024How Many Cases Have You Tried to a Verdict?
-
March 2024Do We Have to Share That Information? Attorney-Client Privilege in the Multi-Entity Context
-
March 2024Sellers of a Business: Know Thyself.
-
September 16, 2022Uber Company Systems Compromised by Widespread Cyber Hack
-
September 15, 2022US Averts Rail Workers Strike With Last-Minute Tentative Deal
-
September 14, 2022Hotter-Than-Expected August Inflation Prompts Massive Wall Street Selloff
Find additional firm contact information for press inquiries.
Find resources to help navigate legal and business complexities.
Generic Launches
Reference Listed Drug, NDA Holder, Generic Drug Name, ANDA Applicant(s), Indication and Launch Date
Spring 2014
Reference Listed Drug | NDA Holder | Generic Drug Name | ANDA Applicant(s) |
Indication | Launch Date |
---|---|---|---|---|---|
Detrol LA |
Pfizer |
Tolterodine Tartrate Extended-Release Capsules |
Teva |
Treatment of overactive bladder with symptoms of urinary frequency, urgency, and incontinence |
1/3/2014
|
Esomeprazole Strontium |
Amneal |
Esomeprazole Strontium Delayed-Release Capsules |
Amneal Pharms |
Gastroesophageal reflux disease (GERD) |
1/6/2014 |
Detrol LA |
Pfizer |
Tolterodine Tartrate Extended-Release Capsules |
Mylan |
Treatment of overactive bladder with symptoms of urinary frequency, urgency, and incontinence |
1/7/2014 |
Micardis |
Boehringer Ingelheim |
Telmisartan Immediate-Release Tablets |
Actavis |
Hypertension |
1/8/2014 |
Micardis |
Boehringer Ingelheim |
Telmisartan Immediate-Release Tablets |
Roxane Labs |
Hypertension |
1/8/2014 |
Myfortic |
Novartis |
Mycophenolic Acid Delayed-Release Tablets |
Mylan |
Prophylaxis of organ rejection in adult patients receiving a kidney transplant and for the prophylaxis of organ rejection in pediatric patients 5 years of age and older who are at least 6 months post kidney transplant |
1/9/2014 |
Vanos |
Medicis |
Fluocinonide Cream 0.1% |
Perrigo |
Relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses in patients 12 years of ago or older |
1/14/2014 |
Lanoxin |
Covis Pharma |
Digoxin Tablets |
Par Pharms |
Treatment of mild to moderate heart failure in adults, increasing myocardial contractility in pediatric patients with heart failure; and control of resting ventricular rate in patients with chronic atrial fibrillation in adults |
1/16/2014 |
Prandin |
Novo Nordisk |
Repaglinide Tablets |
Mylan |
As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus |
1/23/2014 |
Prandin |
Novo Nordisk |
Repaglinide Tablets |
Perrigo |
As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus |
1/24/2014 |
Hectorol |
Genzyme |
Doxercalciferol Injection Vials |
Sandoz |
Treatment of secondary hyperparathyroidism in patients with chronic kidney disease on dialysis |
2/5/2014 |
Hectorol |
Genzyme |
Doxercalciferol Capsules |
Roxane Labs |
Treatment of secondary hyperparathyroidism in patients with chronic kidney disease on dialysis |
2/18/2014 |
Imitrex STATdose Pen |
Glaxo Group Limited |
Sumatriptan Injection USP, Autoinjector System 6 |
Dr. Reddy's Labs |
Migraine headaches with or without aura |
2/25/2014 |
Micardis |
Boehringer Ingelheim |
Telmisartan / Hydrochlorothiazide Tablets |
Roxane Labs |
Hypertension |
2/28/2014 |
Evista |
Eli Lilly |
Raloxifene Tablets |
Teva |
Treat or prevent osteoporosis in postmenopausal women |
3/4/2014 |
Avelox |
Bayer / Merck Sharp & Dohme Corp. |
Moxifloxacin Hydrochloride Tablets |
Dr. Reddy's Labs |
Bacterial infections of theskin, sinuses, lungs, or stomach |
3/5/2014 |
Xeloda |
Genentech |
Capecitabine Tablets |
Teva |
Treatment of breast cancer and colon or rectum cancer that has spread to other parts of the body |
3/7/2014 |
Naloxone Hydrochloride Injection |
Hospira |
Naloxone Hydrochloride Injection |
Mylan |
Indicated for the complete or partial reversal of opioid depression, including respiratory depression, induced by natural and synthetic opioids including propoxyphene, methadone, and certain mixed agonist-antagonist analgesics |
3/11/2014 |
Hectorol |
Genzyme |
Doxercalciferol Capsules |
Prasco Laboratories |
Treatment of secondary hyperparathyroidism in patients with chronic kidney disease on dialysis |
3/11/2014 |
Neptazane |
Lederle |
Methazolamide Tablets |
Perrigo |
Treatment of ocular conditions where lowering intraocular pressure is likely to be of therapeutic benefit, such as chronic open-angle glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma where lowering the intraocular pressure is desired before surgery |
3/12/2014 |
Niaspan |
AbbVie |
Niacin Extended-Release Tablets |
Lupin |
Reduce elevated TC, LDL-C, Apo B and TG levels, and to increase HDL-C in patients with primary hyperlipidemia and mixed dyslipidemia |
3/21/2014 |
Caduet |
Pfizer |
Amlodipine Besylate / Atorvastatin Calcium Tablets |
Dr. Reddy's Labs |
Hypertension or Angina |
3/27/2014 |
Prevpac |
Takeda |
lansoprazole Capsules / Amoxicillin Capsules / Clarithromycin Tablets |
Sandoz |
Eradication of H. pylori infection in patients with duodenal ulcer disease |
3/27/2014 |
Related Publications
Related News
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.